Search results for "Infectious Diseases"
COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies
Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020
Pandemic enters new phase with end of PHE
COVID-19 isn't gone, but the end of the U.S. public health emergency does mark some significant changes.
https://immattersacp.org/archives/2023/06/pandemic-enters-new-phase-with-end-of-phe.htm
1 Jun 2023
Boosters, antithrombotic therapy, mental health effects, more COVID-19 news
FDA advisors recommended booster administration for the Moderna vaccine for certain populations, an ACP/Annals forum covered the immunology of SARS-CoV-2, a trial showed that neither aspirin nor apixaban benefited outpatients with COVID-19, and ACP partnered with YouTube to combat medical misinformation related to COVID-19.
https://immattersacp.org/weekly/archives/2021/10/19/2.htm
19 Oct 2021
CDC releases interim monkeypox guidance, reports epidemiologic and clinical characteristics
The interim guidance focused on prevention and treatment of monkeypox in persons with HIV infection. The most frequently reported signs and symptoms from recent cases of monkeypox in the U.S. include rash (100%), fever (63%), chills (59%), and lymphadenopathy (59%).
https://immattersacp.org/weekly/archives/2022/08/16/1.htm
16 Aug 2022
Most specialty e-consults appropriate, reduced in-person visits in one health system
A study found that about 70% of electronic consultations to five high-volume specialties were appropriate, ranging from 61% for rheumatology to 78% for psychiatry.
https://immattersacp.org/weekly/archives/2020/04/14/5.htm
14 Apr 2020
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020
Telemedicine's time has arrived
As the need for remote health care expands, medical educators and residents continue to refine the best ways to teach and learn telemedicine.
https://immattersacp.org/archives/2022/09/telemedicines-time-has-arrived.htm
1 Sep 2022
Busting COVID-19 vaccination myths
Misinformation and disinformation campaigns have contributed to the death toll of the COVID-19 pandemic. Internists can effectively counter this and encourage vaccinations.
https://immattersacp.org/archives/2021/11/busting-covid-19-vaccination-myths.htm
1 Nov 2021